Forbion Capital Fund IV Cooperatief U.A. 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 07:00 am Sale | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | Forbion Capital Fund IV Cooperatief U.A. | 5,795,364 5.800% | -335,715 (-5.48%) | Filing |
| 2021-02-16 06:38 am Purchase | 2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Forbion Capital Fund IV Cooperatief U.A. | 6,131,079 13.490% | 6,131,079 (New Position) | Filing |